Page last updated: 2024-10-29

imipramine and Pigmentary Retinopathy

imipramine has been researched along with Pigmentary Retinopathy in 1 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Research Excerpts

ExcerptRelevanceReference
" He recovered after the resumption of imipramine but the visual hallucinations persisted."3.69Charles Bonnet syndrome with major depression in a Chinese middle-aged man. ( Fong, SY; Wing, YK, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fong, SY1
Wing, YK1

Other Studies

1 other study available for imipramine and Pigmentary Retinopathy

ArticleYear
Charles Bonnet syndrome with major depression in a Chinese middle-aged man.
    The Australian and New Zealand journal of psychiatry, 1997, Volume: 31, Issue:5

    Topics: Adult; Antidepressive Agents, Tricyclic; China; Cultural Characteristics; Delusions; Depressive Diso

1997